Our Mission: Cure Desmoid Tumors
The Desmoid Tumor Research Foundation (DTRF) empowers and unites everyone committed to finding answers for the desmoid tumor community. We aggressively fund desmoid tumor research, accelerate the development of improved therapies, drive collaborations among clinicians and researchers worldwide, and support patients and doctors through education. Our goal is to find a cure for each and every patient diagnosed with this rare disease.
Learn more about submitting a grant proposal.
EXPLORE THE RESEARCH WE’VE FUNDED AT PRESTIGIOUS INSTITUTIONS AROUND THE WORLD.
| Year | Principal Investigator | Award Title | |
|---|---|---|---|
| Year2019 | Principal InvestigatorJesse Boehm, PhD, Associate Director of the Cancer Program, Director of the Cancer Cell Line Factory, Principal Investigator in the Cancer Model Development Center, Institute Scientist, The Broad Institute of MIT and Harvard | Award Title“Using genome-scale CRISPR screening to create a desmoid tumor dependency map.” Year 1 of 3 | View Project |
| Year2018 | Principal InvestigatorKris Vleminckx, PhD, Ghent University, Belgium | Award Title“Identifying targets for therapy in a novel genetic Xenopus model for desmoid tumor formation.” Year 3 of 3 | View Project |
| Year2018 | Principal InvestigatorBenjamin Alman, MD, and Mushriq Al-Jazrawe, HBSc, PhD Candidate, The Hospital for Sick Children, Toronto, Ontario, Canada | Award Title“Single cell-derived clonal analysis of desmoid tumors to investigate tumor-stroma interactions.” Year 3 of 3. | View Project |
| Year2018 | Principal InvestigatorPeter Hohenberger, MD, PhD, Medical Faculty, Mannheim, University of Heidelberg, Germany | Award Title“An evidence-based consensus on the treatment of desmoids/aggressive fibromatosis.” Year 1 of 1. | View Project |
| Year2018 | Principal InvestigatorBenjamin Wilke, MD, and Steven Attia, DO, Mayo Clinic | Award Title“A pilot study of intralesional injection of triamcinolone acetonide for desmoid tumors.” Year 1 of 1. | View Project |
| Year2018 | Principal InvestigatorO. Hans Iwenofu, MD, FCAP, and Michael Freitas, PhD, The Ohio State University | Award Title“Quantitative proteomics analysis of desmoid-type fibromatosis.” Year 1 of 1. | View Project |
| Year2018 | Principal InvestigatorBenjamin Alman, MD, Duke University | Award Title“A genetically targeted mouse model of desmoid tumors.” Year 1 of 1. | View Project |
| Year2018 | Principal InvestigatorBenjamin Alman, MD, Duke University and Kelly Mercier, PhD, RTI International, | Award Title“Stable isotope resolved metabolomics to interrogate the interactions between stroma and desmoid tumors.” Year 1 of 2 | View Project |
| Year2018 | Principal InvestigatorRaphael E. Pollock, MD, PhD, The Ohio State University | Award Title“The role of the tumor microenvironment in S45F desmoid tumor chemotherapeutic resistance.” Year 1 of 2. | View Project |
| Year2018 | Principal InvestigatorGerlinde Wernig, MD, Assistant Professor of Pathology, Stanford University School of Medicine | Award Title“c-Jun-inducible mice, to study the pathomechanism of desmoid-type fibromatosis in vivo with particular attention to the role of b-catenin/wnt and Notch pathways.” Year 1 of 2 | View Project |
Clinicians & Researchers Newsletter
Receive monthly updates about treatment advances, grant applications, clinical trials, CME opportunities, and more.
